Press Releases

OncoSec Medical Announces Positive Interim Data from Phase 2 Study of OMS-I100 in Metastatic Melanoma

Dec 16, 2013

OncoSec Medical Announces Hire of Chief Medical Officer

Dec 12, 2013

OncoSec Medical to Present at the 6th Annual LD Micro Conference

Nov 26, 2013

OncoSec Medical Announces Positive Preliminary Safety Data in Combination Study

Oct 8, 2013

OncoSec CEO Punit Dhillon to Present at INTERFACE 2013 Digital Health Summit

Oct 4, 2013

OncoSec Medical to Present at the 12th Annual BIO Investor Forum

Oct 3, 2013

OncoSec Medical to Present at the Cancer Vaccines and Gene Therapy Meeting

Oct 1, 2013

OncoSec Announces Melanoma Development Strategy

Sep 24, 2013

OncoSec Medical to Present at the 2013 Aegis Capital Healthcare Conference

Sep 20, 2013

OncoSec Medical Closes $12 Million Public Offering

Sep 19, 2013